• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

6,366
2,300
1,861
1,850
1,725

COUNTRY

868
650
270
253
211

CATEGORIES

  • 858
  • 186
  • 679
  • 1,126
  • 391
  • 270
  • 255
  • 65
  • 379
  • 693
  • 1,330
  • 1,355
  • 625
  • 884
  • 1,695
  • 2,677
  • 507
  • 732
  • 0
  • 93

PRICE

7,155
12,253
18,495
25,176

PUBLISHED

1,693
2,628
7,176
25,176

PRODUCT TYPE

21,051
2,901
873
164
75
44
21
21
19
6
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE
Acorda Therapeutics Inc,(ACOR) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Acorda Therapeutics Inc,(ACOR) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Acorda Therapeutics Inc,(ACOR) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Acorda Therapeutics Inc (ACOR), plus vital industry benchmarks and extensive operating ratios, along with...

October 2013
FROM
Actavis Inc,(ACT) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Actavis Inc,(ACT) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Actavis Inc,(ACT) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Actavis Inc (ACT), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM
Aegerion Pharmaceuticals, Inc.,(AEGR) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Aegerion Pharmaceuticals, Inc.,(AEGR) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Aegerion Pharmaceuticals, Inc.,(AEGR) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Aegerion Pharmaceuticals, Inc. (AEGR), plus vital industry benchmarks and extensive operating ratios, along...

October 2013
FROM
AEterna Zentaris Inc,(AEZS) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages AEterna Zentaris Inc,(AEZS) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

AEterna Zentaris Inc,(AEZS) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for AEterna Zentaris Inc (AEZS), plus vital industry benchmarks and extensive operating ratios, along with an...

October 2013
FROM
Alkermes plc,(ALKS) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Alkermes plc,(ALKS) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Alkermes plc,(ALKS) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Alkermes plc (ALKS), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM
Allergan Inc,(AGN) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Allergan Inc,(AGN) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Allergan Inc,(AGN) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Allergan Inc (AGN), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM
Atrium Innovations Inc,(ATB) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Atrium Innovations Inc,(ATB) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Atrium Innovations Inc,(ATB) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Atrium Innovations Inc (ATB), plus vital industry benchmarks and extensive operating ratios, along with an...

October 2013
FROM
Avanir Pharmaceuticals,(AVNR) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Avanir Pharmaceuticals,(AVNR) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Avanir Pharmaceuticals,(AVNR) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Avanir Pharmaceuticals (AVNR), plus vital industry benchmarks and extensive operating ratios, along with...

October 2013
FROM
Columbia Laboratories Inc,(CBRX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Columbia Laboratories Inc,(CBRX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Columbia Laboratories Inc,(CBRX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Columbia Laboratories Inc (CBRX), plus vital industry benchmarks and extensive operating ratios, along with...

October 2013
FROM
Comvita Limited,(CVNZF) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Comvita Limited,(CVNZF) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Comvita Limited,(CVNZF) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Comvita Limited (CVNZF), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM
JinZangHuang Tibet Pharmaceuticals Inc,(JZHG) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages JinZangHuang Tibet Pharmaceuticals Inc,(JZHG) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

JinZangHuang Tibet Pharmaceuticals Inc,(JZHG) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for JinZangHuang Tibet Pharmaceuticals Inc (JZHG), plus vital industry benchmarks and extensive operating ratios,...

October 2013
FROM
Kane Biotech Inc.,(KNE) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Kane Biotech Inc.,(KNE) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Kane Biotech Inc.,(KNE) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Kane Biotech Inc. (KNE), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM
Meda AB,(MDABF) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Meda AB,(MDABF) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Meda AB,(MDABF) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Meda AB (MDABF), plus vital industry benchmarks and extensive operating ratios, along with an analysis of...

October 2013
FROM
Protect Pharmaceutical Corp,(PRTT) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Protect Pharmaceutical Corp,(PRTT) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Protect Pharmaceutical Corp,(PRTT) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Protect Pharmaceutical Corp (PRTT), plus vital industry benchmarks and extensive operating ratios, along...

October 2013
FROM
Teva Pharmaceutical Industries Ltd,(TEVA) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Teva Pharmaceutical Industries Ltd,(TEVA) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Teva Pharmaceutical Industries Ltd,(TEVA) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Teva Pharmaceutical Industries Ltd (TEVA), plus vital industry benchmarks and extensive operating ratios,...

October 2013
FROM
Theragenics Corp,(TGX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Theragenics Corp,(TGX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Theragenics Corp,(TGX) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Theragenics Corp (TGX), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM
UCB SA,(UCBJF) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages UCB SA,(UCBJF) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

UCB SA,(UCBJF) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for UCB SA (UCBJF), plus vital industry benchmarks and extensive operating ratios, along with an analysis of...

October 2013
FROM
Unigene Laboratories Inc,(UGNEQ) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Unigene Laboratories Inc,(UGNEQ) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Unigene Laboratories Inc,(UGNEQ) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Unigene Laboratories Inc (UGNEQ), plus vital industry benchmarks and extensive operating ratios, along with...

October 2013
FROM
Viratech Corp,(VIRA) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages Viratech Corp,(VIRA) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

Viratech Corp,(VIRA) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Viratech Corp (VIRA), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM
ViroPharma Inc,(VPHM) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages ViroPharma Inc,(VPHM) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages - Product Thumbnail Image

ViroPharma Inc,(VPHM) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratio and Financial Averages

Why You Should Buy This Report: A value-packed package of corporate financial analysis, for ViroPharma Inc (VPHM), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

October 2013
FROM
Loading Indicator

Our Clients

Our clients' logos